(MORN) Morningstar - Ratings and Ratios
Data, Analytics, Ratings, Portfolios, Retirement
MORN EPS (Earnings per Share)
MORN Revenue
Description: MORN Morningstar October 30, 2025
Morningstar, Inc. (NASDAQ:MORN) is a global provider of independent investment research and data, operating across North America, Europe, Asia-Pacific and other regions. The firm’s business is organized into five primary segments: Morningstar Data & Analytics, PitchBook, Morningstar Wealth, Morningstar Credit, and Morningstar Retirement, each delivering subscription-based software, research, and managed-investment products such as mutual funds, ETFs, and model portfolios.
Key growth levers include the rapid expansion of private-market data via PitchBook (which has seen double-digit annual revenue growth, driven by heightened venture-capital and private-equity activity) and the increasing demand for ESG and sustainability analytics supplied by Sustainalytics. In FY 2024, Morningstar reported subscription revenue of roughly $1.1 billion, representing about 78 % of total revenue, and a trailing-12-month operating margin of ~ 15 %, reflecting the high-margin nature of its SaaS-centric model. The company’s exposure to macro-drivers such as interest-rate cycles (affecting credit-rating services) and discretionary investment spending (impacting wealth-management tools) adds a layer of cyclicality to its earnings.
For a deeper dive into Morningstar’s valuation metrics, the ValueRay platform offers a granular, data-driven view of its financials and peer comparisons.
MORN Stock Overview
| Market Cap in USD | 8,773m |
| Sub-Industry | Financial Exchanges & Data |
| IPO / Inception | 2005-05-03 |
MORN Stock Ratings
| Growth Rating | -33.5% |
| Fundamental | 83.9% |
| Dividend Rating | 47.9% |
| Return 12m vs S&P 500 | -46.3% |
| Analyst Rating | 4.0 of 5 |
MORN Dividends
| Dividend Yield 12m | 0.86% |
| Yield on Cost 5y | 0.90% |
| Annual Growth 5y | 1.69% |
| Payout Consistency | 95.9% |
| Payout Ratio | 18.4% |
MORN Growth Ratios
| Growth Correlation 3m | -94.4% |
| Growth Correlation 12m | -89.8% |
| Growth Correlation 5y | 44.5% |
| CAGR 5y | -2.93% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.07 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.25 |
| Sharpe Ratio 12m | -0.62 |
| Alpha | -55.25 |
| Beta | 1.000 |
| Volatility | 25.73% |
| Current Volume | 376.2k |
| Average Volume 20d | 339.7k |
| Stop Loss | 204.4 (-3.4%) |
| Signal | -0.66 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (376.0m TTM) > 0 and > 6% of Revenue (6% = 143.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -1.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.41% (prev 5.70%; Δ -4.29pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 539.1m > Net Income 376.0m (YES >=105%, WARN >=100%) |
| Net Debt (568.4m) to EBITDA (679.7m) ratio: 0.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (42.6m) change vs 12m ago -1.39% (target <= -2.0% for YES) |
| Gross Margin 60.93% (prev 54.56%; Δ 6.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 67.25% (prev 62.43%; Δ 4.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.09 (EBITDA TTM 679.7m / Interest Expense TTM 68.9m) >= 6 (WARN >= 3) |
Altman Z'' 3.65
| (A) 0.01 = (Total Current Assets 979.2m - Total Current Liabilities 945.5m) / Total Assets 3.56b |
| (B) 0.54 = Retained Earnings (Balance) 1.91b / Total Assets 3.56b |
| (C) 0.14 = EBIT TTM 488.5m / Avg Total Assets 3.56b |
| (D) 0.88 = Book Value of Equity 1.79b / Total Liabilities 2.04b |
| Total Rating: 3.65 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.87
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 4.24% = 2.12 |
| 3. FCF Margin 16.45% = 4.11 |
| 4. Debt/Equity 0.69 = 2.27 |
| 5. Debt/Ebitda 0.84 = 1.98 |
| 6. ROIC - WACC (= 6.23)% = 7.79 |
| 7. RoE 23.66% = 1.97 |
| 8. Rev. Trend 98.05% = 7.35 |
| 9. EPS Trend 75.44% = 3.77 |
What is the price of MORN shares?
Over the past week, the price has changed by -2.96%, over one month by -5.35%, over three months by -21.56% and over the past year by -35.58%.
Is Morningstar a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MORN is around 159.90 USD . This means that MORN is currently overvalued and has a potential downside of -24.46%.
Is MORN a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MORN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 278.3 | 31.5% |
| Analysts Target Price | 278.3 | 31.5% |
| ValueRay Target Price | 179 | -15.4% |
MORN Fundamental Data Overview November 05, 2025
P/E Trailing = 24.2662
P/E Forward = 19.802
P/S = 3.6624
P/B = 5.9109
Beta = 1.0
Revenue TTM = 2.40b USD
EBIT TTM = 488.5m USD
EBITDA TTM = 679.7m USD
Long Term Debt = 698.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = 39.9m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 568.4m USD (from netDebt column, last quarter)
Enterprise Value = 9.30b USD (8.77b + Debt 1.04b - CCE 514.5m)
Interest Coverage Ratio = 7.09 (Ebit TTM 488.5m / Interest Expense TTM 68.9m)
FCF Yield = 4.24% (FCF TTM 394.1m / Enterprise Value 9.30b)
FCF Margin = 16.45% (FCF TTM 394.1m / Revenue TTM 2.40b)
Net Margin = 15.70% (Net Income TTM 376.0m / Revenue TTM 2.40b)
Gross Margin = 60.93% ((Revenue TTM 2.40b - Cost of Revenue TTM 935.9m) / Revenue TTM)
Gross Margin QoQ = 60.85% (prev 61.89%)
Tobins Q-Ratio = 2.61 (Enterprise Value 9.30b / Total Assets 3.56b)
Interest Expense / Debt = 3.74% (Interest Expense 39.0m / Debt 1.04b)
Taxrate = 25.51% (31.4m / 123.1m)
NOPAT = 363.9m (EBIT 488.5m * (1 - 25.51%))
Current Ratio = 1.04 (Total Current Assets 979.2m / Total Current Liabilities 945.5m)
Debt / Equity = 0.69 (Debt 1.04b / totalStockholderEquity, last quarter 1.51b)
Debt / EBITDA = 0.84 (Net Debt 568.4m / EBITDA 679.7m)
Debt / FCF = 1.44 (Net Debt 568.4m / FCF TTM 394.1m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.57% (Net Income 376.0m / Total Assets 3.56b)
RoE = 23.66% (Net Income TTM 376.0m / Total Stockholder Equity 1.59b)
RoCE = 21.35% (EBIT 488.5m / Capital Employed (Equity 1.59b + L.T.Debt 698.6m))
RoIC = 15.20% (NOPAT 363.9m / Invested Capital 2.39b)
WACC = 8.97% (E(8.77b)/V(9.82b) * Re(9.70%) + D(1.04b)/V(9.82b) * Rd(3.74%) * (1-Tc(0.26)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.47%
[DCF Debug] Terminal Value 73.71% ; FCFE base≈414.0m ; Y1≈445.9m ; Y5≈548.6m
Fair Price DCF = 175.1 (DCF Value 7.20b / Shares Outstanding 41.1m; 5y FCF grow 8.65% → 3.0% )
EPS Correlation: 75.44 | EPS CAGR: 71.34% | SUE: 0.74 | # QB: 0
Revenue Correlation: 98.05 | Revenue CAGR: 10.00% | SUE: 0.04 | # QB: 0
Additional Sources for MORN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle